Orange Book product · Generic (ANDA)
NABUMETONE
NABUMETONE
At a glance
Feb 25, 2002
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 25, 2002
24 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
NABUMETONE
Strength
500MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 075590
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NABUMETONE
- 1991RELAFENBrand (NDA)
NDA 019583 · SMITHKLINE BEECHAM
- 2025NABUMETONEGeneric (ANDA)
ANDA 219118 · NOVITIUM PHARMA
- 2019NABUMETONEGeneric (ANDA)
ANDA 203166 · LGM PHARMA
- 2011NABUMETONEGeneric (ANDA)
ANDA 090427 · MPP PHARMA
- 2011NABUMETONEGeneric (ANDA)
ANDA 091083 · WATSON LABS
- 2011NABUMETONEGeneric (ANDA)
ANDA 090445 · ANNORA PHARMA
- 2010NABUMETONEGeneric (ANDA)
ANDA 090516 · AUROBINDO PHARMA USA
- 2009NABUMETONEGeneric (ANDA)
ANDA 079093 · OXFORD PHARMS
- 2008NABUMETONEGeneric (ANDA)
ANDA 078420 · SCIEGEN PHARMS
- 2008NABUMETONEGeneric (ANDA)
ANDA 078671 · INVAGEN PHARMS
- 2003NABUMETONEGeneric (ANDA)
ANDA 076009 · CHARTWELL MOLECULES
- 2002NABUMETONEGeneric (ANDA)
ANDA 075280 · CHARTWELL RX
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
